Global Health President Saurabh Upadhyay appointed

What happened

Global Health (NSE: MEDANTA) informed the stock exchanges on 2 November 2026 at 05:26 PM that Saurabh Upadhyay, President, has been appointed.

Company snapshot

Global Health is a mid-cap company in the Healthcare sector, with a market value of about ₹34,910 crore.

The stock last traded at ₹1,298.4, against a 52-week range of ₹956–₹1,544 (15.9% below the high).

Before this filing the shares had moved −10.2% over the month and −10.3% over three months. Average daily turnover over the last 20 sessions was about ₹26.59 crore.

Promoters held 33.00% at the end of Q1 FY27. Foreign institutions owned 9.46% and domestic institutions 16.89%.

What history shows

BCEIE's records show 3 previous management change filings from the company since May 2026.

Across 112 similar disclosures by other Healthcare companies, shares moved +1.0% on average the next day and +1.7% over five days; 49% of them rose the next day.

Market-wide, 4,084 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• The appointment of a successor and any change in strategy or guidance.
• 3 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• World Conference on Traditional Medicine 2026 delivers landmark outcomes for global health — World Health Organization (WHO), 30 Oct 2026
• Income, not geography, drives global health coverage gaps: Study — Down To Earth, 28 Oct 2026
• Lancet: climate change should be treated as a global health emergency — Gavi, the Vaccine Alliance, 28 Oct 2026
• Call For New WHO Instrument To Address Climate-Driven Global Health Emergency — Health Policy Watch, 29 Oct 2026
• Climate Change Must Be Declared "Global Health Emergency": Report — NDTV, 28 Oct 2026

Source

• Exchange filing (PDF)